244 related articles for article (PubMed ID: 26030909)
21. Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide.
Li H; Yuan X; Yan D; Li D; Guan F; Dong Y; Wang H; Liu X; Yang B
Cell Physiol Biochem; 2017; 42(3):1192-1201. PubMed ID: 28668966
[TBL] [Abstract][Full Text] [Related]
22. Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.
Deng S; Wong CKC; Lai HC; Wong AST
Oncotarget; 2017 Apr; 8(16):25897-25914. PubMed ID: 27825116
[TBL] [Abstract][Full Text] [Related]
23. CD90
Xue BZ; Xiang W; Zhang Q; Wang HF; Zhou YJ; Tian H; Abdelmaksou A; Xue J; Sun MX; Yi DY; Xiong NX; Jiang XB; Zhao HY; Fu P
Stem Cell Res Ther; 2021 Jul; 12(1):394. PubMed ID: 34256854
[TBL] [Abstract][Full Text] [Related]
24. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.
Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S
Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730
[TBL] [Abstract][Full Text] [Related]
25. Diverse Targets of β-Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse.
Chang YW; Su YJ; Hsiao M; Wei KC; Lin WH; Liang CL; Chen SC; Lee JL
Cancer Res; 2015 Aug; 75(16):3398-410. PubMed ID: 26122848
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p.
Mandal S; Gamit N; Varier L; Dharmarajan A; Warrier S
Life Sci; 2021 Jan; 265():118854. PubMed ID: 33278391
[TBL] [Abstract][Full Text] [Related]
27. Antrodia camphorata inhibits epithelial-to-mesenchymal transition by targeting multiple pathways in triple-negative breast cancers.
Hseu YC; Chang GR; Pan JY; Rajendran P; Mathew DC; Li ML; Liao JW; Chen WT; Yang HL
J Cell Physiol; 2019 Apr; 234(4):4125-4139. PubMed ID: 30146779
[TBL] [Abstract][Full Text] [Related]
28. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
29. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
Lan F; Pan Q; Yu H; Yue X
J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372
[TBL] [Abstract][Full Text] [Related]
30. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
Tso JL; Yang S; Menjivar JC; Yamada K; Zhang Y; Hong I; Bui Y; Stream A; McBride WH; Liau LM; Nelson SF; Cloughesy TF; Yong WH; Lai A; Tso CL
Mol Cancer; 2015 Nov; 14():189. PubMed ID: 26546412
[TBL] [Abstract][Full Text] [Related]
31. Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells.
Koch K; Hartmann R; Schröter F; Suwala AK; Maciaczyk D; Krüger AC; Willbold D; Kahlert UD; Maciaczyk J
Oncotarget; 2016 Nov; 7(45):73414-73431. PubMed ID: 27705917
[TBL] [Abstract][Full Text] [Related]
32. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
[TBL] [Abstract][Full Text] [Related]
33. Bile acid: a potential inducer of colon cancer stem cells.
Farhana L; Nangia-Makker P; Arbit E; Shango K; Sarkar S; Mahmud H; Hadden T; Yu Y; Majumdar AP
Stem Cell Res Ther; 2016 Dec; 7(1):181. PubMed ID: 27908290
[TBL] [Abstract][Full Text] [Related]
34. Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules.
Zhu T; Li X; Luo L; Wang X; Li Z; Xie P; Gao X; Song Z; Su J; Liang G
J Transl Med; 2015 Nov; 13():356. PubMed ID: 26563263
[TBL] [Abstract][Full Text] [Related]
35. Cdc20 overexpression is involved in temozolomide-resistant glioma cells with epithelial-mesenchymal transition.
Wang J; Zhou F; Li Y; Li Q; Wu Z; Yu L; Yuan F; Liu J; Tian Y; Cao Y; Zhao Y; Zheng Y
Cell Cycle; 2017; 16(24):2355-2365. PubMed ID: 29108461
[TBL] [Abstract][Full Text] [Related]
36. Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases.
Choi EJ; Cho BJ; Lee DJ; Hwang YH; Chun SH; Kim HH; Kim IA
BMC Cancer; 2014 Jan; 14():17. PubMed ID: 24418474
[TBL] [Abstract][Full Text] [Related]
37. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway.
Wang Z; Wang N; Li W; Liu P; Chen Q; Situ H; Zhong S; Guo L; Lin Y; Shen J; Chen J
Carcinogenesis; 2014 Oct; 35(10):2346-56. PubMed ID: 25085904
[TBL] [Abstract][Full Text] [Related]
38. The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines.
Visweswaran M; Arfuso F; Dilley RJ; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2018 Feb; 95():63-72. PubMed ID: 29277675
[TBL] [Abstract][Full Text] [Related]
39. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.
Kim SM; Woo JS; Jeong CH; Ryu CH; Jang JD; Jeun SS
Stem Cells Transl Med; 2014 Feb; 3(2):172-82. PubMed ID: 24436439
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
